Form 8-K - Current report:
SEC Accession No. 0001564590-20-021322
Filing Date
2020-05-05
Accepted
2020-05-05 16:55:31
Documents
16
Period of Report
2020-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cc-8k_20200505.htm   iXBRL 8-K 59644
2 EX-99.1 cc-ex991_6.htm EX-99.1 952545
3 GRAPHIC gap4103yatzs000001.jpg GRAPHIC 37502
4 GRAPHIC gap4103yatzs000005.jpg GRAPHIC 6148
5 GRAPHIC geyclffvarg1000001.jpg GRAPHIC 2872
  Complete submission text file 0001564590-20-021322.txt   1250897

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cc-20200505.xsd EX-101.SCH 5770
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cc-20200505_lab.xml EX-101.LAB 18727
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cc-20200505_pre.xml EX-101.PRE 11169
9 EXTRACTED XBRL INSTANCE DOCUMENT cc-8k_20200505_htm.xml XML 3394
Mailing Address 1007 MARKET STREET WILMINGTON DE 19801
Business Address 1007 MARKET STREET WILMINGTON DE 19801 302 773 1000
Chemours Co (Filer) CIK: 0001627223 (see all company filings)

EIN.: 464845564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36794 | Film No.: 20849752
SIC: 2800 Chemicals & Allied Products